BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 962 filers reported holding BAXTER INTL INC in Q3 2014. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,181 | -18.4% | 481,745 | -1.5% | 0.04% | -12.0% |
| Q2 2023 | $22,278 | +6.5% | 488,992 | -5.2% | 0.05% | +2.0% |
| Q1 2023 | $20,916 | -21.7% | 515,682 | -1.6% | 0.05% | -25.8% |
| Q4 2022 | $26,699 | -99.9% | 523,821 | -2.4% | 0.07% | -12.0% |
| Q3 2022 | $28,898,000 | -16.8% | 536,548 | -0.8% | 0.08% | -11.8% |
| Q2 2022 | $34,731,000 | -18.3% | 540,730 | -1.3% | 0.08% | -2.3% |
| Q1 2022 | $42,493,000 | -9.5% | 548,017 | +0.2% | 0.09% | -4.4% |
| Q4 2021 | $46,939,000 | +5.5% | 546,817 | -1.2% | 0.09% | -3.2% |
| Q3 2021 | $44,509,000 | -3.1% | 553,390 | -3.0% | 0.09% | -2.1% |
| Q2 2021 | $45,937,000 | -8.7% | 570,652 | -4.3% | 0.10% | -11.1% |
| Q1 2021 | $50,300,000 | -0.5% | 596,391 | -5.4% | 0.11% | -1.8% |
| Q4 2020 | $50,569,000 | -6.4% | 630,222 | -6.2% | 0.11% | -16.0% |
| Q3 2020 | $54,045,000 | -7.1% | 672,037 | -0.6% | 0.13% | -10.3% |
| Q2 2020 | $58,204,000 | +3.7% | 675,999 | -2.3% | 0.15% | -14.1% |
| Q1 2020 | $56,151,000 | -5.4% | 691,605 | -2.6% | 0.17% | +23.2% |
| Q4 2019 | $59,379,000 | -8.0% | 710,105 | -3.7% | 0.14% | -15.3% |
| Q3 2019 | $64,525,000 | +6.2% | 737,685 | -0.6% | 0.16% | +5.8% |
| Q2 2019 | $60,782,000 | -3.1% | 742,147 | -3.8% | 0.15% | -3.1% |
| Q1 2019 | $62,751,000 | +19.9% | 771,755 | -2.9% | 0.16% | +7.4% |
| Q4 2018 | $52,316,000 | -15.7% | 794,831 | -1.2% | 0.15% | +2.1% |
| Q3 2018 | $62,038,000 | +2.4% | 804,754 | -1.9% | 0.14% | -2.0% |
| Q2 2018 | $60,569,000 | +6.6% | 820,269 | -6.1% | 0.15% | +7.2% |
| Q1 2018 | $56,827,000 | -0.3% | 873,720 | -0.9% | 0.14% | +2.2% |
| Q4 2017 | $57,018,000 | +3.0% | 882,089 | 0.0% | 0.14% | -2.2% |
| Q3 2017 | $55,351,000 | +3.3% | 882,089 | -0.3% | 0.14% | +0.7% |
| Q2 2017 | $53,581,000 | +16.0% | 885,051 | -0.6% | 0.14% | +16.1% |
| Q1 2017 | $46,173,000 | +10.7% | 890,347 | -5.4% | 0.12% | +8.3% |
| Q4 2016 | $41,713,000 | +0.2% | 940,754 | +7.6% | 0.11% | -0.9% |
| Q3 2016 | $41,609,000 | -2.4% | 874,136 | -7.3% | 0.11% | -1.8% |
| Q2 2016 | $42,652,000 | +10.1% | 943,216 | +0.0% | 0.11% | +9.8% |
| Q1 2016 | $38,730,000 | +7.7% | 942,803 | +0.0% | 0.10% | +7.4% |
| Q4 2015 | $35,965,000 | +16.2% | 942,723 | +0.0% | 0.10% | +9.2% |
| Q3 2015 | $30,964,000 | -55.6% | 942,584 | -5.4% | 0.09% | -51.9% |
| Q2 2015 | $69,712,000 | +0.1% | 996,888 | -2.0% | 0.18% | +2.3% |
| Q1 2015 | $69,669,000 | -53.6% | 1,017,064 | -50.4% | 0.18% | -6.8% |
| Q4 2014 | $150,148,000 | +103.2% | 2,048,694 | +98.9% | 0.19% | -2.1% |
| Q3 2014 | $73,908,000 | -1.8% | 1,029,787 | -1.1% | 0.19% | -1.0% |
| Q2 2014 | $75,284,000 | -4.8% | 1,041,267 | -3.1% | 0.20% | -5.8% |
| Q1 2014 | $79,078,000 | +1.5% | 1,074,727 | -4.0% | 0.21% | +3.0% |
| Q4 2013 | $77,894,000 | -0.5% | 1,119,974 | -6.0% | 0.20% | -6.0% |
| Q3 2013 | $78,295,000 | -8.4% | 1,191,893 | -3.5% | 0.22% | -10.8% |
| Q2 2013 | $85,515,000 | – | 1,234,517 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |